Infinity Pharmaceuticals, Inc. (INFI) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1155969,
    "name": "Infinity Pharmaceuticals, Inc.",
    "stock_name": "Infinity Pharmaceuticals, Inc.",
    "full_name": "Infinity Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/infinity-pharmaceuticals-inc",
    "exchange": 206,
    "exchangecode": "OTC",
    "country_id": 2,
    "currency": "USD",
    "cmp": "0.00",
    "chg": 0,
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "0.00",
    "mcapval": "0.00",
    "mcap": "",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US45665G3039",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "562 ",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/infinity-pharmaceuticals-inc-1155969-206&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Infinity Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-infinity-pharmaceuticals-inc-technically-bullish-or-bearish-3546501",
        "imagepath": "",
        "date": "2025-09-20 19:34:23",
        "description": "As of 29 November 2024, the technical trend for Infinity Pharmaceuticals, Inc. has changed from sideways to mildly bearish. The daily moving averages indicate a mildly bearish stance, while the weekly MACD and KST are both mildly bullish. However, the absence of signals in the RSI and the sideways Bollinger Bands suggest a lack of momentum. Overall, the current technical stance is mildly bearish. \n\nIn terms of returns, the stock has significantly underperformed compared to the S&P 500 over the past three, five, and ten years, with returns of -99.99% versus the S&P's 70.41%, 96.61%, and 231.64%, respectively...."
      },
      {
        "title": "Is Infinity Pharmaceuticals, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-infinity-pharmaceuticals-inc-overvalued-or-undervalued-3543068",
        "imagepath": "",
        "date": "2025-09-20 18:09:46",
        "description": "As of 8 July 2024, the valuation grade for Infinity Pharmaceuticals, Inc. has moved from risky to does not qualify, indicating a significant deterioration in its investment appeal. Based on the available metrics, the company appears to be overvalued given its negative EV to EBIT (-0.73), negative EV to EBITDA (-0.74), and an extremely high ROE of 109.47%, which is misleading due to negative capital employed. \n\nIn comparison with peers, Avalo Therapeutics, Inc. has a P/E of -2.6865 and an EV to EBITDA of -0.6568, while ABVC BioPharma, Inc. shows a P/E of -20.1140 and an EV to EBITDA of -23.1803, both indicating that Infinity's ratios are not competitive. Furthermore, Infinity's stock has dramatically underperformed against the S&P 500 over the past three years and five years, with returns of -99.99% compared to the S&P 500's 70.41% and 96.61%, respectively, reinforcing the notion that the stock is currently ..."
      }
    ],
    "total": 5,
    "sid": "1155969",
    "stock_news_url": "https://www.marketsmojo.com/news/infinity-pharmaceuticals-inc-1155969"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Infinity Pharmaceuticals, Inc. technically bullish or bearish?

2025-09-20 19:34:23

As of 29 November 2024, the technical trend for Infinity Pharmaceuticals, Inc. has changed from sideways to mildly bearish. The daily moving averages indicate a mildly bearish stance, while the weekly MACD and KST are both mildly bullish. However, the absence of signals in the RSI and the sideways Bollinger Bands suggest a lack of momentum. Overall, the current technical stance is mildly bearish. In terms of returns, the stock has significantly underperformed compared to the S&P 500 over the past three, five, and ten years, with returns of -99.99% versus the S&P's 70.41%, 96.61%, and 231.64%, respectively....

Is Infinity Pharmaceuticals, Inc. overvalued or undervalued?

2025-09-20 18:09:46

As of 8 July 2024, the valuation grade for Infinity Pharmaceuticals, Inc. has moved from risky to does not qualify, indicating a significant deterioration in its investment appeal. Based on the available metrics, the company appears to be overvalued given its negative EV to EBIT (-0.73), negative EV to EBITDA (-0.74), and an extremely high ROE of 109.47%, which is misleading due to negative capital employed. In comparison with peers, Avalo Therapeutics, Inc. has a P/E of -2.6865 and an EV to EBITDA of -0.6568, while ABVC BioPharma, Inc. shows a P/E of -20.1140 and an EV to EBITDA of -23.1803, both indicating that Infinity's ratios are not competitive. Furthermore, Infinity's stock has dramatically underperformed against the S&P 500 over the past three years and five years, with returns of -99.99% compared to the S&P 500's 70.41% and 96.61%, respectively, reinforcing the notion that the stock is currently ...

View All News